Evidence map›Paper›PMID 38915209›Full record

Observational studyJournal of basic and clinical physiology and pharmacology2024

Long-term functional outcomes and predictors of efficacy in thulium laser enucleation of the prostate (ThuLEP) for benign prostatic hyperplasia (BPH): a retrospective observational study.

Lorenzo Spirito, Massimo Capra, Carmine Sciorio, Lorenzo Romano, Michele Morelli, Adelio Valtorta, Davide Arcaniolo, Benito Fabio Mirto, Celeste Manfredi, Enrico Sicignano and 8 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of basic and clinical physiology and pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. [Impact of thulium laser enucleation of the prostateBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Lorenzo SpiritoUnit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli" Naples, Italy.
Massimo CapraUrology Unit, 9337 Alessandro Manzoni Hospital , Lecco, Italy.
Carmine SciorioUrology Unit, 9337 Alessandro Manzoni Hospital , Lecco, Italy.
Lorenzo RomanoUrology Unit, 9337 Alessandro Manzoni Hospital , Lecco, Italy.
Michele MorelliUrology Unit, 9337 Alessandro Manzoni Hospital , Lecco, Italy.
Adelio ValtortaUrology Unit, 89497 Moriggia Pelascini Hospital , Como, Italy.
Davide ArcanioloUnit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli" Naples, Italy.
Benito Fabio MirtoDepartment of Neurosciences, Science of Reproduction and Odontostomatology, 9307 University of Naples Federico II Naples, Italy.
Celeste ManfrediUnit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli" Naples, Italy.
Enrico SicignanoDepartment of Neurosciences, Science of Reproduction and Odontostomatology, 9307 University of Naples Federico II Naples, Italy.ORCID https://orcid.org/0000-0003-2725-8530
Federico CaponeDepartment of Neurosciences, Science of Reproduction and Odontostomatology, 9307 University of Naples Federico II Naples, Italy.
Gaetano GiampagliaDepartment of Neurosciences, Science of Reproduction and Odontostomatology, 9307 University of Naples Federico II Naples, Italy.
Salvatore IaconisDepartment of Neurosciences, Science of Reproduction and Odontostomatology, 9307 University of Naples Federico II Naples, Italy.
Luigi NapolitanoDepartment of Neurosciences, Science of Reproduction and Odontostomatology, 9307 University of Naples Federico II Naples, Italy.
Fabio MachiellaDepartment of Neurosciences, Science of Reproduction and Odontostomatology, 9307 University of Naples Federico II Naples, Italy.
Carmelo QuattroneUnit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli" Naples, Italy.
Vittorio ImperatoreUrology Unit, Moscati Hospital, Avellino, Italy.
Felice CrocettoUnit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli" Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesBenign prostatic hyperplasia (BPH) is a common urological condition affecting aging men worldwide. Among the treatment options available for BPH, transurethral resection of the prostate (TURP) is the gold-standard invasive intervention. To reduce the TURP-related non-negligible morbidity, loss-of-ejaculation rate, hospitalization, blood loss and catheterization time several laser techniques have been developed, such as the Thulium Laser Enucleation of the Prostate (ThuLEP). To investigate the efficacy outcomes of the ThuLEP as a treatment option for benign prostatic hyperplasia (BPH) we performed a retrospective observational study at Moriggia Pelascini Hospital (Como, Italy) between January 2015 and September 2018.

methodsWe included 265 patients who underwent ThuLEP at a specific hospital between defined dates. Data on various parameters, including post-void residue volume, peak urinary flow rate (Qmax), International Prostate Symptom Score (IPSS) for urinary symptoms, IPSS Quality of Life (QoL) score, and International Index of Erectile Function (IIEF) score for erectile dysfunction, were collected at baseline and follow-up.

resultsThe analysis revealed significant improvements in voiding efficiency, urinary flow, urinary symptoms, quality of life, and erectile function following ThuLEP. Furthermore, certain baseline characteristics, such as post-void residue, peak urinary flow rate, age, prostate volume, and aspirin usage, were found to influence treatment outcomes.

conclusionsDespite the study's limitations, these findings contribute to understanding ThuLEP's effectiveness in managing BPH and can aid in making informed clinical decisions for patient care. Prospective studies with longer follow-up periods are recommended to validate and extend these results.

Indexed as

Laser TherapyProstatic HyperplasiaQuality of LifeThuliumAgedAged, 80 and overHumansMaleMiddle AgedProstateRetrospective StudiesTreatment OutcomeThuliumbenign prostatic hyperplasiaendourologylaser

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.